| scholarly article | Q13442814 |
| P2093 | author name string | Patel AJ | |
| Marcu KB | |||
| Bossone SA | |||
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 52 | |
| P304 | page(s) | 809-860 | |
| P577 | publication date | 1992-01-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Annual Review of Biochemistry | Q567356 |
| P1476 | title | myc function and regulation | |
| P478 | volume | 61 |
| Q44659670 | 12-O-Tetradecanoylphorbol-13-acetate and UV Radiation-induced Nucleoside Diphosphate Protein Kinase B Mediates Neoplastic Transformation of Epidermal Cells |
| Q27765734 | 3'-Phosphorylated nucleotides are tight binding inhibitors of nucleoside diphosphate kinase activity |
| Q38297366 | A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors. |
| Q40023931 | A Role for c-myc in Chemically Induced Renal-Cell Death |
| Q38364182 | A computerized database-scan to identify c-MYC targets |
| Q24545231 | A functional YY1 binding site is necessary and sufficient to activate Surf-1 promoter activity in response to serum growth factors |
| Q38572767 | A gastrin transcript expressed in gastrointestinal cancer cells contains an internal ribosome entry site |
| Q40445617 | A novel Myc-target gene, mimitin, that is involved in cell proliferation of esophageal squamous cell carcinoma. |
| Q33957035 | A novel intron element operates posttranscriptionally To regulate human N-myc expression |
| Q24337051 | A novel mechanism of cell growth regulation by Cell Cycle and Apoptosis Regulatory Protein (CARP)-1 |
| Q52708997 | A novel mode for transcription inhibition mediated by PNA-induced R-loops with a model in vitro system. |
| Q28564890 | A novel myc target gene, mina53, that is involved in cell proliferation |
| Q55481055 | A polymorphic variant of human c-Myc: Asn11-->Ser. |
| Q41100373 | A sequence in the 5′ flanking region confers progestin responsiveness on the human c-myc gene |
| Q38336574 | A single nucleotide change in the c-myc internal ribosome entry segment leads to enhanced binding of a group of protein factors |
| Q38307117 | A spectroscopic investigation of the interaction between c-MYC DNA and tetrapyridinoporphyrazinatozinc(II). |
| Q92865151 | A tunable assay for modulators of genome-destabilizing DNA structures |
| Q36559314 | A unique transactivation sequence motif is found in the carboxyl-terminal domain of the single-strand-binding protein FBP |
| Q37269390 | AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations |
| Q40719036 | APC-dependent regulation of ornithine decarboxylase in human colon tumor cells |
| Q35094511 | Aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and oncogenesis |
| Q36081076 | Abnormal pattern of post-gamma-ray DNA replication in radioresistant fibroblast strains from affected members of a cancer-prone family with Li-Fraumeni syndrome |
| Q38338899 | Accelerated Proliferative Senescence of Rat Embryo Fibroblasts after Stable Transfection of Multiple Copies of the c-Myc DNA-Binding Sequence |
| Q39615527 | Acridine-modified, clamp-forming antisense oligonucleotides synergize with cisplatin to inhibit c-Myc expression and B16-F0 tumor progression |
| Q33840451 | Action of Myc in vivo - proliferation and apoptosis |
| Q39446781 | Activity of the c-myc replicator at an ectopic chromosomal location |
| Q47597394 | Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. |
| Q36679535 | Addition of constitutive c-myc expression to Abelson murine leukemia virus changes the phenotype of the cells transformed by the virus from pre-B-cell lymphomas to plasmacytomas |
| Q33971890 | Alteration of the lipid profile in lymphomas induced by MYC overexpression |
| Q77140399 | Altered Differentiation of Hepatocytes in a Transgenic Mouse Model of Hepatocarcinogenesis |
| Q33635836 | Alternative DNA structure formation in the mutagenic human c-MYC promoter |
| Q38036415 | Alternative transcription and alternative splicing in cancer |
| Q77335768 | Amplification of c-myc gene and overexpression of c-Myc protein in breast cancer and adjacent non-neoplastic tissue |
| Q47918368 | Amplification of the translocated c-myc genes in three Burkitt lymphoma cell lines |
| Q37713114 | An ATP-dependent As(III)-glutathione transport system in membrane vesicles of Leishmania tarentolae |
| Q36550858 | An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants |
| Q34395958 | An In Silico Study of the Differential Effect of Oxidation on Two Biologically Relevant G-Quadruplexes: Possible Implications in Oncogene Expression |
| Q40523037 | An analysis of genes regulated by the multi-functional transcriptional regulator Yin Yang-1. |
| Q36549958 | An essential domain of the c-myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation |
| Q24316326 | An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes |
| Q38344632 | Analysis of E-box DNA binding during myeloid differentiation reveals complexes that contain Mad but not Max. |
| Q71259707 | Analysis of human breast cancer nuclear proteins binding to the promoter elements of the c-myc gene |
| Q39542252 | Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and the nuclear compartment |
| Q40916857 | Analysis of the murine AhR gene promoter |
| Q74688728 | Animal and cellular studies on carcinogenic effects of low frequency (50/60-Hz) magnetic fields |
| Q33556878 | Antiproliferative properties of the USF family of helix-loop-helix transcription factors |
| Q70480057 | Antisense of oligonucleotides and the inhibition of oncogene expression |
| Q40551607 | Apoptosis in viral infections |
| Q35855075 | Apparent uncoupling of oncogenicity from fibroblast transformation and apoptosis in a mutant myc gene transduced by feline leukemia virus |
| Q42832476 | Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product |
| Q73097705 | B-Myc is preferentially expressed in hormonally-controlled tissues and inhibits cellular proliferation |
| Q73615245 | BLIMP-1: trigger for differentiation of myeloid lineage |
| Q36166789 | Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway |
| Q34367152 | Bcr is a negative regulator of the Wnt signalling pathway |
| Q36671153 | Bile salts increase epithelial cell proliferation through HuR-induced c-Myc expression |
| Q48056857 | Binding of THZif-1, a MAZ-like zinc finger protein to the nuclease-hypersensitive element in the promoter region of the c-MYC protooncogene |
| Q41142636 | Biological aspects of multiple myeloma |
| Q38363473 | Biosensor detection of triplex formation by modified oligonucleotides |
| Q41011016 | Butyrate and the colonocyte. Implications for neoplasia |
| Q39811440 | Bystin-like protein is upregulated in hepatocellular carcinoma and required for nucleologenesis in cancer cell proliferation |
| Q41131125 | C-myc deregulation during transformation induction: involvement of 7SK RNA. |
| Q43956063 | C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells |
| Q77408505 | C-myc is not involved in cadmium-elicited apoptotic pathway in porcine kidney LLC-PK1 cells |
| Q36827796 | CTCF, a conserved nuclear factor required for optimal transcriptional activity of the chicken c-myc gene, is an 11-Zn-finger protein differentially expressed in multiple forms |
| Q40864791 | Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis |
| Q41175989 | Cdc25 cell-cycle phosphatase as a target of c-myc |
| Q40787482 | Cdc25A phosphatase suppresses apoptosis induced by serum deprivation |
| Q36690298 | Cell cycle regulation of the c-Myc transcriptional activation domain |
| Q73445322 | Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity |
| Q64389573 | Cellular nucleic acid binding protein regulates the CT element of the human c-myc protooncogene |
| Q34449018 | Characterization of cis-regulatory elements of the c-myc promoter responding to human GM-CSF or mouse interleukin 3 in mouse proB cell line BA/F3 cells expressing the human GM-CSF receptor |
| Q42807945 | Characterization of the superinduction of the c-myc proto-oncogene in fibroblasts by benzamide derivatives |
| Q41338905 | Chromatin structure and function: the heretical path to an RNA transcription factor |
| Q34786043 | Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression |
| Q73595120 | Clinical implication of altered expression of Mad1 protein in human breast carcinoma |
| Q38300748 | Cloning and sequence of the feline max, and max 9 transcripts |
| Q35621945 | Competition between RNA-binding proteins CELF1 and HuR modulates MYC translation and intestinal epithelium renewal |
| Q42802893 | Consensus-interferon and platelet-derived growth factor adversely regulate proliferation and migration of Kaposi's sarcoma cells by control of c-myc expression |
| Q28580840 | Constitutive heat shock protein 70 interacts with α-enolase and protects cardiomyocytes against oxidative stress |
| Q33985770 | Contrasting roles for Myc and Mad proteins in cellular growth and differentiation |
| Q38866151 | Cooverexpression of EpCAM and c-myc genes in malignant breast tumours. |
| Q36694963 | Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses |
| Q24805890 | Cryptic promoter activity in the DNA sequence corresponding to the pim-1 5'-UTR |
| Q41495304 | Cyclic AMP downregulates c-myc expression by inhibition of transcript initiation in human B-precursor Reh cells |
| Q36562487 | Cyclin D3 sensitizes tumor cells to tumor necrosis factor-induced, c-Myc-dependent apoptosis |
| Q33887377 | Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. |
| Q40568061 | Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathway |
| Q32118758 | Cytokine-induced restoration of differentiation and cell cycle arrest in v-Myc transformed U-937 monoblasts correlates with reduced Myc activity |
| Q41600302 | DNA Conformation, Topology, and the Regulation of c-myc Expression |
| Q35208818 | DNA damage checkpoint control in cells exposed to ionizing radiation |
| Q37051064 | DNA secondary structures: stability and function of G-quadruplex structures |
| Q28262361 | DNA tetraplex formation in the control region of c-myc |
| Q34468606 | Decrease in nucleoside diphosphate kinase (NDPK/nm23) expression during hematopoietic maturation. |
| Q40626921 | Decreased c-Myc expression and its involvement in X-ray-induced apoptotic cell death of human T-cell leukaemia cell line MOLT-4. |
| Q28203672 | Defective interplay of activators and repressors with TFIH in xeroderma pigmentosum |
| Q34637234 | Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program |
| Q41481874 | Defining a role for c-Myc in breast tumorigenesis. |
| Q52174737 | Definition of the human N-myc promoter region during development in a transgenic mouse model |
| Q28575519 | Deregulated expression of a novel component of TFTC/STAGA histone acetyltransferase complexes, rat SGF29, in hepatocellular carcinoma: possible implication for the oncogenic potential of c-Myc |
| Q52199791 | Deregulated expression of c-myc in megakaryocytes of transgenic mice increases megakaryopoiesis and decreases polyploidization |
| Q41006195 | Developmentally regulated Xist promoter switch mediates initiation of X inactivation. |
| Q35957689 | Differences in the molecular structure of c-myc-activating recombinations in murine plasmacytomas and precursor cells |
| Q72805213 | Different biological effects of the two protein kinase C activators bryostatin-1 and TPA on human carcinoma cell lines |
| Q41600312 | Differential Regulation of the c-MYC P1 and P2 Promoters in the Absence of Functional Tumor Suppressors: Implications for Mechanisms of Deregulated MYC Transcription |
| Q40902087 | Differential effects of retinoic acid on growth and apoptosis in human colon cancer cell lines associated with the induction of retinoic acid receptor beta |
| Q73040900 | Differential expression of c-jun and c-myc in N-nitroso diethylamine-induced hepatic oncogenesis in AKR mice |
| Q38273722 | Differential regulation of MAP kinase cascade in human colorectal tumorigenesis |
| Q40241741 | Differential regulation of early response genes and cell proliferation through the human granulocyte macrophage colony-stimulating factor receptor: selective activation of the c-fos promoter by genistein |
| Q38347268 | Differential regulation of the N-myc proto-oncogene by ROR alpha and RVR, two orphan members of the superfamily of nuclear hormone receptors |
| Q33847130 | Differentiation and proliferation of pulmonary neuroendocrine cells |
| Q41379257 | Differentiation and transdifferentiation of the retinal pigment epithelium. |
| Q33536280 | Differentiation inhibitory factor Nm23 as a prognostic factor for acute myeloid leukemia |
| Q37719286 | Differentiation of the immortalized adult neuronal progenitor cell line HC2S2 into neurons by regulatable suppression of the v-myc oncogene |
| Q24535577 | Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription |
| Q34026482 | Disentangling the MYC web. |
| Q35078774 | Disrupting TP53 in mouse models of human cancers |
| Q42798685 | Distinct Roles for MAX Protein Isoforms in Proliferation and Apoptosis |
| Q36556463 | Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene? |
| Q40881227 | ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1). |
| Q42983917 | Early response gene signalling in bryostatin-stimulated primary B chronic lymphocytic leukaemia cells in vitro |
| Q40863839 | Ectopic expression of Rsu-1 results in elevation of p21CIP and inhibits anchorage-independent growth of MCF7 breast cancer cells |
| Q38724038 | Effect of teicoplanin on the expression of c-myc and c-fos proto-oncogenes in MCF-7 breast cancer cell line |
| Q52177924 | Effects of EGF and TGFbeta1 on c-myc gene expression and DNA synthesis in embryonic hamster palate mesenchymal cells |
| Q40887267 | Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells |
| Q42475428 | Effects of polyamines, polyamine synthesis inhibitors, and polyamine analogs on casein kinase II using Myc oncoprotein as substrate |
| Q42088472 | Elevated polyamines induce c-MYC overexpression by perturbing quadruplex-WC duplex equilibrium |
| Q41063703 | Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells. |
| Q41099346 | Essential role of optimal protein synthesis in preventing the apoptotic death of cultured B cell hybridomas |
| Q39149804 | Establishment of an immortal chicken embryo liver-derived cell line |
| Q36562367 | Exon 2-mediated c-myc mRNA decay in vivo is independent of its translation |
| Q31152796 | Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis |
| Q41152233 | Exposure of embryonic cells to alcohol: contrasting effects during preimplantation and postimplantation development |
| Q31916381 | Expression cloning in Fe2+ transport defective yeast of a novel maize MYC transcription factor |
| Q61700558 | Expression of hpttg proto-oncogene in lymphoid neoplasias |
| Q60300456 | Expression of the human antimicrobial peptide β-defensin-1 is repressed by the EGFR-ERK-MYC axis in colonic epithelial cells |
| Q35071112 | FBPs are calibrated molecular tools to adjust gene expression |
| Q100416084 | FUBP1 and FUBP2 enforce distinct epigenetic setpoints for MYC expression in primary single murine cells |
| Q36940362 | Four-stranded DNA: cancer, gene regulation and drug development |
| Q28198743 | Function and regulation of the transcription factors of the Myc/Max/Mad network |
| Q36567857 | Function of the c-Myc antagonist Mad1 during a molecular switch from proliferation to differentiation |
| Q34183768 | Function of the c-Myc oncoprotein in chromatin remodeling and transcription. |
| Q38360599 | Functional analysis of Burkitt's lymphoma mutant c-Myc proteins |
| Q34442961 | Functional analysis of the AUG- and CUG-initiated forms of the c-Myc protein |
| Q40913568 | Functional aspects of apoptosis in hematopoiesis and consequences of failure |
| Q22009062 | Functional domains of c-myc promoter binding protein 1 involved in transcriptional repression and cell growth regulation |
| Q35885872 | Functions of myc:max in the control of cell proliferation and tumorigenesis |
| Q41264865 | Gastrin stimulates expression of protooncogene c-myc through a process involving polyamines in IEC-6 cells |
| Q36135022 | Genes related to growth and invasiveness are repressed by sodium butyrate in ovarian carcinoma cells. |
| Q40553433 | Genetic alterations in prostate adenocarcinoma. |
| Q34344691 | Genetic basis of pituitary adenoma invasiveness: a review |
| Q73978688 | Genetic changes in prostate cancer |
| Q43968784 | Genetic variants at chromosome 8q24, colorectal epithelial cell proliferation, and risk for incident, sporadic colorectal adenomas |
| Q33355172 | Genome-wide analysis of alternative promoters of human genes using a custom promoter tiling array |
| Q33350623 | Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells |
| Q28278072 | Genomic Organization and Expression of a Human Gene for Myc-associated Zinc Finger Protein (MAZ) |
| Q41178239 | Genomic instability in MycER-activated Rat1A-MycER cells |
| Q44133878 | Glutathione influences c-Myc-induced apoptosis in M14 human melanoma cells |
| Q35915994 | Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc |
| Q40557274 | HER2 signaling enhances 5'UTR-mediated translation of c-Myc mRNA. |
| Q24310037 | HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity |
| Q40790676 | Healthy mice with an altered c-myc gene: role of the 3' untranslated region revisited |
| Q34811629 | Heterogeneous nuclear ribonucleoprotein C modulates translation of c-myc mRNA in a cell cycle phase-dependent manner |
| Q24649693 | Heterogeneous nuclear ribonucleoprotein K is a transcription factor |
| Q37195219 | How the c-myc promoter works and why it sometimes does not. |
| Q36853031 | Human SWI/SNF drives sequence-directed repositioning of nucleosomes on C-myc promoter DNA minicircles |
| Q41204966 | Human T-cell leukemia virus type I tax masks c-Myc function through a cAMP-dependent pathway |
| Q34124162 | Human c-Myc isoforms differentially regulate cell growth and apoptosis in Drosophila melanogaster |
| Q36959489 | Human telomere, oncogenic promoter and 5'-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics |
| Q41096536 | Hydrogen peroxide-induced expression of the proto-oncogenes, c-jun, c-fos and c-myc in rabbit lens epithelial cells |
| Q52845594 | Hypermethylation of PRDM1/Blimp-1 promoter in extranodal NK/T-cell lymphoma, nasal type: an evidence of predominant role in its downregulation |
| Q33640342 | I-motif structures formed in the human c-MYC promoter are highly dynamic--insights into sequence redundancy and I-motif stability |
| Q42265040 | IL-6-induced stimulation of c-myc translation in multiple myeloma cells is mediated by myc internal ribosome entry site function and the RNA-binding protein, hnRNP A1. |
| Q98779269 | Identification and Characterization of MAPK Signaling Pathway Genes and Associated lncRNAs in the Ileum of Piglets Infected by Clostridium perfringens Type C |
| Q24684304 | Identification of a large Myc-binding protein that contains RCC1-like repeats |
| Q40790463 | Identification of amino acid-base contacts in the Myc-DNA complex by site-specific bromouracil mediated photocrosslinking |
| Q24310637 | Identification of c- MYC as a Target of the APC Pathway |
| Q38760910 | Identification of pathway-based prognostic gene signatures in patients with multiple myeloma |
| Q34455807 | Identification of substrates and regulators of the mitogen-activated protein kinase ERK5 using chimeric protein kinases. |
| Q40392540 | Identification of two enhancer elements downstream of the human c-myc gene |
| Q78121372 | Implication of c-Myc in apoptosis induced by the retinoid CD437 in human lung carcinoma cells |
| Q90333802 | In Silico Screening and Binding Characterization of Small Molecules toward a G-Quadruplex Structure Formed in the Promoter Region of c-MYC Oncogene |
| Q39718464 | In vivo generation of 3' and 5' truncated species in the process of c-myc mRNA decay |
| Q71610816 | Inactivation of tumor suppressor genes and deregulation of the c-myc gene in urothelial cancer cell lines |
| Q36398127 | Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-myc |
| Q30979181 | Increasing alternative promoter repertories is positively associated with differential expression and disease susceptibility |
| Q54431566 | Inducement of G-quadruplex DNA forming and down-regulation of oncogene c-myc by bile acid-amino acid conjugate-BAA. |
| Q35043420 | Induction of apoptosis in cancer: new therapeutic opportunities |
| Q72275803 | Induction of apoptosis in oxygen-deprived cultures of hybridoma cells |
| Q71977685 | Influence of portein tyrosine phosphorylation on the experssion of the c‐myc oncogene in cancer of the large bowel |
| Q38339025 | Inhibition of Transcription of the Human c-myc Protooncogene by Intermolecular Triplex |
| Q41065536 | Inhibition of cell growth in CaCO2 cells by the polyamine analogue N1,N12-bis(ethyl)spermine is preceded by a reduction in MYC oncoprotein levels |
| Q42672020 | Insulin-like Growth Factor I Induction of c-myc Expression in Bovine Fibroblasts Can Be Blocked by Antecedent Insulin Receptor Activation |
| Q31132980 | Integrating Multi-omics Data to Dissect Mechanisms of DNA repair Dysregulation in Breast Cancer |
| Q37152966 | Integrative Functional Genomics Implicates EPB41 Dysregulation in Hepatocellular Carcinoma Risk |
| Q31077729 | Integrative gene expression profiling reveals G6PD-mediated resistance to RNA-directed nucleoside analogues in B-cell neoplasms |
| Q45754525 | Interactive Effects of c-myc and Transforming Growth Factor α Transgenes on Liver Tumor Development in Simian Virus 40 T Antigen Transgenic Mice |
| Q28355608 | Internal ribosome entry segment-mediated initiation of c-Myc protein synthesis following genotoxic stress |
| Q25257689 | Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death |
| Q38357468 | Invasion of the CAG triplet repeats by a complementary peptide nucleic acid inhibits transcription of the androgen receptor and TATA-binding protein genes and correlates with refolding of an active nucleosome containing a unique AR gene sequence |
| Q71679015 | Inverse expressions of the N-myc oncogene and beta 1 integrin in human neuroblastoma: relationships to disease progression in a nude mouse model system |
| Q40921623 | Is mucinous carcinoma of the colorectum a distinct genetic entity? |
| Q37256435 | It's T-ALL about Notch |
| Q36403645 | Janus‐faced role of SIRT1 in tumorigenesis |
| Q41520889 | K252a: a new blocker of the cell-cycle at G1 phase in a human hepatoma cell line |
| Q24816975 | Kinetic resolution of bimolecular hybridization versus intramolecular folding in nucleic acids by surface plasmon resonance: application to G-quadruplex/duplex competition in human c-myc promoter |
| Q41583865 | Kips off to Myc: Implications for TGFβ signaling |
| Q39757012 | Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues |
| Q47986931 | Ligand-induced conformational preorganization of loops of c-MYC G-quadruplex DNA and its implications in structure-specific drug design |
| Q30862704 | Light chain promoter regions in rainbow trout Oncorhynchus mykiss: function of a classical and an atypical Ig promoter. |
| Q71694545 | Long-range chromatin analysis of the human MYC locus by pulsed-field gel electrophoresis |
| Q40387253 | Loss of FBP function arrests cellular proliferation and extinguishes c-myc expression |
| Q53417826 | Loss of USF transcriptional activity in breast cancer cell lines |
| Q34444076 | Loss of cell cycle controls in apoptotic lymphoblasts of the bursa of Fabricius. |
| Q24316955 | MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination |
| Q35848951 | MYC levels govern hematopoietic tumor type and latency in transgenic mice |
| Q38588878 | MYC: connecting selective transcriptional control to global RNA production. |
| Q38092448 | MYC‐y mice: From tumour initiation to therapeutic targeting of endogenous MYC |
| Q40981114 | Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh. |
| Q24310266 | Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation |
| Q53850308 | Mapping and characterization of the minimal internal ribosome entry segment in the human c-myc mRNA 5' untranslated region |
| Q30450274 | Mechanism of c-myc regulation by c-Myb in different cell lineages |
| Q34119143 | Mechanisms of cell-cycle checkpoints: at the crossroads of carcinogenesis and drug discovery |
| Q28771749 | Mechanistic studies for the role of cellular nucleic-acid-binding protein (CNBP) in regulation of c-myc transcription |
| Q34230052 | Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo |
| Q34104558 | Modulation of Endothelial Cell Growth Arrest and Apoptosis by Vascular Endothelial Growth Inhibitor |
| Q28081657 | Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment |
| Q40829383 | Molecular and cytogenetic alterations in early stage of carcinogenesis of human lung |
| Q40922422 | Molecular biology of testicular germ cell tumors: current status |
| Q44587907 | Molecular characterisation and expression profiling of the ENO1 gene in the ovarian follicle of the Sichuan white goose |
| Q48058124 | Molecular cloning and characterization of a gene that encodes a MYC-related protein in Arabidopsis |
| Q42674787 | Molecular cloning, expression and chromosomal localization of mouse MM-1. |
| Q36287900 | Molecular karyotype (amplotype) of metastatic colorectal cancer by unbiased arbitrarily primed PCR DNA fingerprinting |
| Q46844799 | Molecular modeling and biophysical analysis of the c-MYC NHE-III1 silencer element |
| Q39719091 | Molecular weight abnormalities of the CTCF transcription factor: CTCF migrates aberrantly in SDS-PAGE and the size of the expressed protein is affected by the UTRs and sequences within the coding region of the CTCF gene |
| Q73410749 | Mouse model for Burkitt's lymphoma will aid understanding and therapy |
| Q37603401 | Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism |
| Q34610790 | Multiple members of the E2F transcription factor family are the products of oncogenes |
| Q28776786 | Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo |
| Q52168084 | Multiprotein complexes present at the MIF motifs flanking the promoter of the human c-myc gene |
| Q37473327 | Mutational analysis of NM23-H2/NDP kinase identifies the structural domains critical to recognition of a c-myc regulatory element |
| Q37647273 | Mutations in the G-quadruplex silencer element and their relationship to c-MYC overexpression, NM23 repression, and therapeutic rescue |
| Q38329998 | Mxi1 is a repressor of the c-Myc promoter and reverses activation by USF. |
| Q24563644 | Myc and Max: molecular evolution of a family of proto-oncogene products and their dimerization partner |
| Q33612685 | Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis |
| Q34062481 | Myc oncogenes: the enigmatic family |
| Q36711272 | Myc represses transcription of the growth arrest gene gas1 |
| Q36568034 | Myc versus USF: discrimination at the cad gene is determined by core promoter elements |
| Q36678903 | Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2 |
| Q33667285 | Myc-mediated transformation: the repression connection |
| Q38568550 | Myc: the beauty and the beast |
| Q34488830 | N-Myc and SP Regulate Phosphatidylserine Synthase-1 Expression in Brain and Glial Cells |
| Q92255940 | N-Terminal Truncated Myb with New Transcriptional Activity Produced Through Use of an Alternative MYB Promoter in Salivary Gland Adenoid Cystic Carcinoma |
| Q73394985 | N-myc over-expression downregulates alpha3beta1 integrin expression in human Saos-2 osteosarcoma cells |
| Q27655453 | NM23-H2 may play an indirect role in transcriptional activation of c-myc gene expression but does not cleave the nuclease hypersensitive element III1 |
| Q28241326 | Negative control of the Myc protein by the stress-responsive kinase Pak2 |
| Q40021079 | Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc finger repressor CTCF. |
| Q80151845 | Non-incidental coamplification of Myc and ERBB2, and Myc and EGFR, in gastric adenocarcinomas |
| Q42456083 | Novel Transcriptional Mechanisms Are Involved in Regulating Preproenkephalin Gene Expressionin Vivo |
| Q40022897 | Nucleosomal Structures of c-myc Promoters with Transcriptionally Engaged RNA Polymerase II |
| Q41145808 | Nucleosomal structure of active and inactive c-myc genes |
| Q72427599 | Oncogene overexpression in non-small-cell lung cancer tissue: prevalence and clinicopathological significance |
| Q36208087 | Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. |
| Q36664688 | Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis |
| Q74649765 | Over-expression and amplification of the c-myc gene in human urothelial carcinoma |
| Q24290150 | Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts |
| Q41957982 | Overexpression of c-myc in diabetic mice restores altered expression of the transcription factor genes that regulate liver metabolism |
| Q36009698 | Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice |
| Q37702161 | Overview of formation of G-quadruplex structures |
| Q33610890 | PGE2-driven expression of c-Myc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC. |
| Q41510725 | Pathways of p53-dependent apoptosis. |
| Q40625392 | Phosphorylation by Glycogen Synthase Kinase-3 Controls c-Myc Proteolysis and Subnuclear Localization |
| Q28141456 | Physical and functional interaction between two pluripotent proteins, the Y-box DNA/RNA-binding factor, YB-1, and the multivalent zinc finger factor, CTCF |
| Q38820691 | Physiological Expression and Accumulation of the Products of Two Upstream Open Reading Frames mrtl and MycHex1 Along With p64 and p67 Myc From the Human c-myc Locus |
| Q55670934 | Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas |
| Q34053472 | Poly(A) signals and transcriptional pause sites combine to prevent interference between RNA polymerase II promoters. |
| Q42808134 | Polyamine depletion up-regulates c-Myc expression, yet induces G(1) arrest and terminal differentiation of F9 teratocarcinoma stem cells |
| Q38336940 | Polyamine-modulated expression of c-myc plays a critical role in stimulation of normal intestinal epithelial cell proliferation |
| Q28570513 | Polyamines regulate c-Myc translation through Chk2-dependent HuR phosphorylation |
| Q39447889 | Polysaccharides from Capsosiphon fulvescens Stimulate the Growth of Gastrointestinal Cells |
| Q28575652 | Polysaccharides from Capsosiphon fulvescens Stimulate the Growth of IEC-6 Cells by Activating the MAPK Signaling Pathway |
| Q41600319 | Positive and Negative Regulation of c-Myc Transcription |
| Q37713271 | Prevention of diabetic alterations in transgenic mice overexpressing Myc in the liver. |
| Q55510639 | Prognostic significances of overexpression MYC and/or BCL2 in R-CHOP-treated diffuse large B-cell lymphoma: A Systematic review and meta-analysis. |
| Q73006569 | Proliferation, C-myc, and cyclin D1 expression in diffuse alveolar damage: potential roles in pathogenesis and implications for prognosis |
| Q36407796 | Propeller-type parallel-stranded G-quadruplexes in the human c-myc promoter |
| Q39230218 | Psoralen-modified clamp-forming antisense oligonucleotides reduce cellular c-Myc protein expression and B16-F0 proliferation |
| Q24629236 | Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1 |
| Q41247962 | RRR-alpha-tocopheryl succinate induces apoptosis in avian retrovirus-transformed lymphoid cells |
| Q34654334 | Rapid identification of therapeutic targets in hematologic malignancies via functional genomics |
| Q52544957 | Recruitment of TRRAP required for oncogenic transformation by E1A. |
| Q37333643 | Reflecting on 25 years with MYC. |
| Q41600361 | Regulated Expression and Function of the c-Myc Antagonist, Mad1, During a Molecular Switch from Proliferation to Differentiation |
| Q40386886 | Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways. |
| Q41542179 | Regulation of c-myc expression by sodium butyrate in the colon carcinoma cell line Caco-2. |
| Q40897143 | Regulation of c-myc transcription by interleukin-2 (IL-2). Identification of a novel IL-2 response element interacting with STAT-4. |
| Q34325611 | Regulation of gene expression by internal ribosome entry sites or cryptic promoters: the eIF4G story |
| Q41374015 | Regulation of human ornithine decarboxylase expression following prolonged quiescence: role for the c-Myc/Max protein complex |
| Q45159479 | Regulation of the equilibrium between G-quadruplex and duplex DNA in promoter of human c-myc oncogene by a pyrene derivative |
| Q38316453 | Repeated CT elements bound by zinc finger proteins control the absolute and relative activities of the two principal human c-myc promoters |
| Q37343986 | Requirement of cell cycle and apoptosis regulator 1 for target gene activation by Wnt and beta-catenin and for anchorage-independent growth of human colon carcinoma cells |
| Q42712255 | Resveratrol inhibits proliferation, angiogenesis and induces apoptosis in colon cancer cells: calorie restriction is the force to the cytotoxicity |
| Q53475474 | Retrovirus-induced B cell neoplasia in the bursa of Fabricius. |
| Q33874286 | Reversible tumorigenesis by MYC in hematopoietic lineages |
| Q28201539 | Role of 14-3-3epsilon, c-Myc/Max, and Akt phosphorylation in HIV-1 gp 120-induced mesangial cell proliferation |
| Q34170995 | Role of B-lymphocyte-induced maturation protein-1 in terminal differentiation of B cells and other cell lineages |
| Q35853838 | Role of c-myc in simian virus 40 large tumor antigen-induced DNA synthesis in quiescent 3T3-L1 mouse fibroblasts |
| Q34541307 | Role of transcription factors in the pathogenesis of pituitary adenomas: a review |
| Q24310015 | Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor. |
| Q41859014 | SMARCAL1 Negatively Regulates C-Myc Transcription By Altering The Conformation Of The Promoter Region |
| Q37025168 | STK38 is a critical upstream regulator of MYC's oncogenic activity in human B-cell lymphoma. |
| Q34970423 | Selection for c-myc integration sites in polyclonal T-cell lymphomas |
| Q36554700 | Selective and Rapid Nuclear Translocation of a c-Myc-Containing Complex after Fertilization of Xenopus laevis Eggs |
| Q41636913 | Short Chain Fatty Acid Regulation of Intestinal Gene Expression |
| Q43704421 | Short- and long-chain natural polyamines play specific roles in adult cricket neuroblast proliferation and neuron differentiation in vitro |
| Q41517451 | Signaling of programmed cell death induction in WEHI-231 B lymphoma cells |
| Q37409356 | Sin3 corepressor function in Myc-induced transcription and transformation |
| Q33508324 | Small molecule inhibitors of Myc/Max dimerization and Myc-induced cell transformation |
| Q36402664 | Small-molecule interaction with a five-guanine-tract G-quadruplex structure from the human MYC promoter |
| Q27674707 | Solution Structure of a 2:1 Quindoline–c-MYC G-Quadruplex: Insights into G-Quadruplex-Interactive Small Molecule Drug Design |
| Q33193145 | Solution‐Phase Combinatorial Libraries: Modulating Cellular Signaling by Targeting Protein–Protein or Protein–DNA Interactions |
| Q42620818 | Specific inhibition of gene expression and transactivation functions of hepatitis B virus X protein and c-myc by small interfering RNAs |
| Q36305401 | Specific requirement of putrescine for the mitogenic action of juvenile hormone on adult insect neuroblasts |
| Q39168123 | Sphingosine kinase 1 overexpression stimulates intestinal epithelial cell proliferation through increased c-Myc translation |
| Q36293972 | Stabilization of HIF-1α and HIF-2α, up-regulation of MYCC and accumulation of stabilized p53 constitute hallmarks of CNS-PNET animal model |
| Q39918399 | Stable transfection of CHO cells with the c-myc gene results in increased proliferation rates, reduces serum dependency, and induces anchorage independence |
| Q22253226 | Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene |
| Q55475778 | Structural determinants for post-transcriptional stabilization of lactate dehydrogenase A mRNA by the protein kinase C signal pathway. |
| Q33915919 | Structural insights into G-quadruplexes: towards new anticancer drugs |
| Q40964746 | Structural organization and expression of the mouse gene for Pur-1, a highly conserved homolog of the human MAZ gene |
| Q33998447 | Structure of the biologically relevant G-quadruplex in the c-MYC promoter |
| Q71472658 | Structure-activity relationship of 17 structural analogues of n-butyric acid upon c-myc expression |
| Q36978525 | Structures, folding patterns, and functions of intramolecular DNA G-quadruplexes found in eukaryotic promoter regions |
| Q30890618 | Studies characterizing 60 kda autoantibodies in subjects with schizophrenia |
| Q47741818 | Systemic short-chain fatty acids rapidly alter gastrointestinal structure, function, and expression of early response genes |
| Q56963006 | T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC |
| Q41244135 | TATA box and Sp1 sites mediate the activation of c-myc promoter P1 by immunoglobulin kappa enhancers. |
| Q33552252 | TFIIH operates through an expanded proximal promoter to fine-tune c-myc expression |
| Q40797081 | TGF-beta1 regulates the expression of multiple max-interacting transcription factors in Balb/MK cells: implications for understanding the mechanism of action of TGF-beta1. |
| Q71649711 | TGFβ1 inhibits branching morphogenesis and N-myc expression in lung bud organ cultures |
| Q33888207 | Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. |
| Q28281008 | Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells |
| Q41351007 | Targeted melting and binding of a DNA regulatory element by a transactivator of c-myc |
| Q34174883 | Targeting G-quadruplexes in gene promoters: a novel anticancer strategy? |
| Q34352558 | Targeting MYC Expression through G-Quadruplexes |
| Q33594302 | Telomerase activation. One step on the road to cancer? |
| Q34278442 | Tempol suppresses micronuclei formation in astrocytes of newborn rats exposed to 50-Hz, 10-mT electromagnetic fields under bleomycin administration |
| Q28140020 | The FBP interacting repressor targets TFIIH to inhibit activated transcription |
| Q24544008 | The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression |
| Q33791251 | The MYC dualism in growth and death |
| Q33967079 | The Max network gone mad. |
| Q36564631 | The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter |
| Q33667278 | The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation |
| Q38011958 | The Path from Skin to Brain: Generation of Functional Neurons from Fibroblasts |
| Q38748127 | The Regulatory Role of Long Noncoding RNAs in Cancer Drug Resistance. |
| Q33667309 | The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation |
| Q40874517 | The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. |
| Q41600284 | The c-myc Story: Where we’ve been, Where we seem to be Going |
| Q37013896 | The c-myc promoter: still MysterY and challenge |
| Q38302512 | The chromatin structure of the dual c-myc promoter P1/P2 is regulated by separate elements |
| Q36875918 | The cloning and sequencing of an ovine c-myc cDNA. |
| Q27736408 | The crystal structure of an intact human Max-DNA complex: new insights into mechanisms of transcriptional control |
| Q36646471 | The curcumin analogue hydrazinocurcumin exhibits potent suppressive activity on carcinogenicity of breast cancer cells via STAT3 inhibition |
| Q33854150 | The frequencies of micronuclei induced by cisplatin in newborn rat astrocytes are increased by 50-Hz, 7.5- and 10-mT electromagnetic fields |
| Q40636620 | The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc |
| Q24322793 | The human TRIDENT/HFH-11/FKHL16 gene: structure, localization, and promoter characterization |
| Q36655671 | The human cut homeodomain protein represses transcription from the c-myc promoter |
| Q40041349 | The kinetics of simian virus 40-induced progression of quiescent cells into S phase depend on four independent functions of large T antigen |
| Q36752403 | The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene |
| Q38323146 | The mouse Mel-18 "RING-finger" gene: genomic organization, promoter analysis and chromosomal assignment |
| Q36551303 | The myc intron-binding polypeptide associates with RFX1 in vivo and binds to the major histocompatibility complex class II promoter region, to the hepatitis B virus enhancer, and to regulatory regions of several distinct viral genes |
| Q37631442 | The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics |
| Q39445586 | The tmp gene, encoding a membrane protein, is a c-Myc target with a tumorigenic activity |
| Q39716275 | The transactivation potential of a c-Myc N-terminal region (residues 92-143) is regulated by growth factor/Ras signaling |
| Q40519994 | The transcriptional regulation of the preproenkephalin gene |
| Q34242408 | Thermodynamic stability and folding kinetics of the major G-quadruplex and its loop isomers formed in the nuclease hypersensitive element in the human c-Myc promoter: effect of loops and flanking segments on the stability of parallel-stranded intram |
| Q33864266 | Tight junction protein ZO-2 is differentially expressed in normal pancreatic ducts compared to human pancreatic adenocarcinoma |
| Q41687948 | Transcription Factor-Based Drug Design in Anticancer Drug Development |
| Q36580981 | Transcription blockage by homopurine DNA sequences: role of sequence composition and single-strand breaks. |
| Q34173877 | Transcription factors and translocations in lymphoid and myeloid leukemia |
| Q35669591 | Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities. |
| Q36088678 | Transcriptional regulation of mouse delta-opioid receptor gene |
| Q57382164 | Transcriptional regulation of the ornithine decarboxylase gene by c-Myc/Max/Mad network and retinoblastoma protein interacting with c-Myc |
| Q39451978 | Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase |
| Q24313028 | Transcriptional repressor ZF5 identifies a new conserved domain in zinc finger proteins |
| Q44004521 | Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma |
| Q40430362 | Transforming growth factor β and cancer |
| Q41212993 | Transforming growth factor-beta1 modulates p107 function in myeloid cells: correlation with cell cycle progression |
| Q36455522 | Transient excess of MYC activity can elicit genomic instability and tumorigenesis |
| Q53888869 | Translation of the human c-myc P0 tricistronic mRNA involves two independent internal ribosome entry sites. |
| Q33601644 | Translational control of growth factor and proto-oncogene expression |
| Q34405431 | Translocations involving c-myc and c-myc function |
| Q40821740 | Upstream stimulating factor-1 (USF1) and USF2 bind to and activate the promoter of the adenomatous polyposis coli (APC) tumor suppressor gene |
| Q34662891 | What retroviruses teach us about the involvement of c-Myc in leukemias and lymphomas |
| Q73420829 | Wild-type DNA sequence of the N-myc transactivation domain in human neuroblastoma |
| Q37288487 | YY1 and c-Myc associate in vivo in a manner that depends on c-Myc levels |
| Q36827465 | Yin-yang 1 activates the c-myc promoter |
| Q34157211 | You Don't Muck with MYC |
| Q78800431 | Zinc modulates c-Myc/Mad1 balance in human leukemia cells |
| Q77932393 | c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance |
| Q27671022 | c-MYC promoter G-quadruplex formed at the 5'-end of NHE III1 element: insights into biological relevance and parallel-stranded G-quadruplex stability |
| Q53447394 | c-Myc Dependent Initiation of Genomic Instability During Neoplastic Transformation |
| Q45284395 | c-Myc and E2F1 drive PBK/TOPK expression in high-grade malignant lymphomas |
| Q30718377 | c-Myc and Mxi1 immunoreactivities in the calcifying areas of the epiphyseal-plate cartilage matrix of growing rats |
| Q40228722 | c-Myc binds to 5' flanking sequence motifs of the dihydrofolate reductase gene in cellular extracts: role in proliferation |
| Q48062961 | c-Myc expression is controlled by the mitogenic cAMP-cascade in thyrocytes |
| Q33961819 | c-Myc protein synthesis is initiated from the internal ribosome entry segment during apoptosis. |
| Q33962550 | c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells |
| Q33956988 | c-Myc target genes involved in cell growth, apoptosis, and metabolism |
| Q36238451 | c-Myc transactivation of LDH-A: implications for tumor metabolism and growth |
| Q41013204 | c-Myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases |
| Q34771617 | c-Myc-induced extrachromosomal elements carry active chromatin |
| Q38346781 | c-Myc/Max heterodimers bind cooperatively to the E-box sequences located in the first intron of the rat ornithine decarboxylase (ODC) gene |
| Q33967371 | c-myc Internal ribosome entry site activity is developmentally controlled and subjected to a strong translational repression in adult transgenic mice |
| Q40775797 | c-myc box II mutations in Burkitt's lymphoma-derived alleles reduce cell-transformation activity and lower response to broad apoptotic stimuli. |
| Q73174813 | c-myc in bladder cancer. Clinical findings and analysis of mechanism |
| Q38326977 | c-myc intron element-binding proteins are required for 1, 25-dihydroxyvitamin D3 regulation of c-myc during HL-60 cell differentiation and the involvement of HOXB4. |
| Q35212190 | c-myc null cells misregulate cad and gadd45 but not other proposed c-Myc targets |
| Q24315822 | mrtl-A translation/localization regulatory protein encoded within the human c-myc locus and distributed throughout the endoplasmic and nucleoplasmic reticular network |
| Q41299249 | p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines |
| Q35709920 | p53-Dependent induction of PVT1 and miR-1204. |
| Q38288618 | v-Abl activates c-myc transcription through the E2F site |
Search more.